Patent · US Active

Genetically modified non-human animal with human or chimeric CTLA-4

US11071290B2 · kind B2 · utility

0Cited by

7References

13Claims

0Family size

Assignee

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. · CN

Inventors

Yuelei Shen · Beijing, CN
Yanan Guo · Beijing, CN
Yang Bai · Beijing, CN
Jiawei Yao · Beijing, CN
Chengzhang Shang · Beijing, CN
Rui Huang · Beijing, CN

Key dates

Filing date	May 31, 2019
Grant date	Jul 27, 2021
Priority date	—
Expiry date	Jun 4, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/11
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to the genetically modified non-human animals that express a human or chimeric CTLA-4, and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.